ciclopirox and Hand Dermatosis
ciclopirox has been researched along with Hand Dermatosis in 16 studies
Research Excerpts
Excerpt | Relevance | Reference |
---|---|---|
"Our data suggest that a ciclopirox lacquer may be helpful in the treatment of common warts." | 7.71 | [Treatment of therapy refractory verrucae vulgares with a ciclopirox-containing lacquer]. ( Landthaler, M; Reisberger, EM; Szeimies, RM; Wimmershoff, MB, 2001) |
" Nail avulsion followed by long-term occlusive application of ciclopiroxolamine cleared the onychomycosis, whereas the sole and palm infection was resistant to ciclopiroxolamine and glutaraldehyde treatment." | 7.67 | Hendersonula toruloidea infection: successful response of onychomycosis to nail avulsion and topical ciclopiroxolamine. ( Johansson, S; Rollman, O, 1987) |
"Ciclopirox is a synthetic hydroxypyridone antifungal agent." | 6.41 | Dermatopharmacology of ciclopirox nail lacquer topical solution 8% in the treatment of onychomycosis. ( Bohn, M; Kraemer, KT, 2000) |
"A decision analytic model was developed to evaluate the pharmacoeconomic profiles of itraconazole-continuous (Sporanox, Janssen Pharmaceutica), itraconazole-pulse (Sporanox, Janssen Pharmaceutica), terbinafine (Lamisil, Novartis Pharmaceuticals), and ciclopirox (Penlac, Dermik Laboratories) in the treatment of fingernail and toenail onychomycosis." | 4.82 | Economic analysis of oral and topical therapies for onychomycosis of the toenails and fingernails. ( Amaya, K; Arikian, S; Casciano, J; Doyle, J; Haspel, M; Kahler, K; Shear, N, 2003) |
"To assess the daily treatment costs and the average cost-effectiveness of three topical onychomycosis therapies - amorolfine 5% and ciclopirox 8% nail lacquers and tioconazole 28% nail solution - when used as indicated in France, the UK, Germany and Italy." | 3.73 | Treatment costs of three nail lacquers used in onychomycosis. ( Adjadj, L; Jäckel, A; Lambert, J; Marty, JP, 2005) |
"Our data suggest that a ciclopirox lacquer may be helpful in the treatment of common warts." | 3.71 | [Treatment of therapy refractory verrucae vulgares with a ciclopirox-containing lacquer]. ( Landthaler, M; Reisberger, EM; Szeimies, RM; Wimmershoff, MB, 2001) |
" Nail avulsion followed by long-term occlusive application of ciclopiroxolamine cleared the onychomycosis, whereas the sole and palm infection was resistant to ciclopiroxolamine and glutaraldehyde treatment." | 3.67 | Hendersonula toruloidea infection: successful response of onychomycosis to nail avulsion and topical ciclopiroxolamine. ( Johansson, S; Rollman, O, 1987) |
"Ciclopirox is a synthetic hydroxypyridone antifungal agent." | 2.41 | Dermatopharmacology of ciclopirox nail lacquer topical solution 8% in the treatment of onychomycosis. ( Bohn, M; Kraemer, KT, 2000) |
"Onychomycosis is a challenging fungal infection to treat topically, likely due to the unique properties of the nail plate." | 1.34 | In Vitro penetration of a novel oxaborole antifungal (AN2690) into the human nail plate. ( Akama, T; Baker, SJ; Barbadillo, S; Cashmore, AK; Hold, KM; Hui, X; Maibach, HI; Plattner, JJ; Sanders, V; Wester, RC; Zhang, YK, 2007) |
"This report presents original methods to assess the bioavailability of an antifungal drug from a varnish preparation in finger nails." | 1.28 | Ciclopirox nail lacquer 8%: in vivo penetration into and through nails and in vitro effect on pig skin. ( Ceschin-Roques, CG; Hänel, H; Luc, J; Michel, G; Pruja-Bougaret, SM; Vandermander, J, 1991) |
Research
Studies (16)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (6.25) | 18.7374 |
1990's | 6 (37.50) | 18.2507 |
2000's | 7 (43.75) | 29.6817 |
2010's | 2 (12.50) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors
Authors | Studies |
---|---|
Lipner, S | 1 |
Scher, RK | 2 |
Seidl, HP | 1 |
Jäckel, A | 2 |
Müller, J | 1 |
Schaller, M | 1 |
Borelli, C | 1 |
Polak, A | 1 |
Casciano, J | 1 |
Amaya, K | 1 |
Doyle, J | 1 |
Arikian, S | 1 |
Shear, N | 1 |
Haspel, M | 1 |
Kahler, K | 1 |
Marty, JP | 1 |
Lambert, J | 1 |
Adjadj, L | 1 |
Sardana, K | 1 |
Garg, VK | 1 |
Manchanda, V | 1 |
Rajpal, M | 1 |
Figueiredo, VT | 1 |
de Assis Santos, D | 1 |
Resende, MA | 1 |
Hamdan, JS | 1 |
Hui, X | 1 |
Baker, SJ | 1 |
Wester, RC | 1 |
Barbadillo, S | 1 |
Cashmore, AK | 1 |
Sanders, V | 1 |
Hold, KM | 1 |
Akama, T | 1 |
Zhang, YK | 1 |
Plattner, JJ | 1 |
Maibach, HI | 1 |
Cohen, PR | 1 |
Liony, C | 1 |
Joly, P | 1 |
Balguerie, X | 1 |
Fusade, T | 1 |
Lauret, P | 1 |
Bohn, M | 1 |
Kraemer, KT | 1 |
Szeimies, RM | 1 |
Wimmershoff, MB | 1 |
Reisberger, EM | 1 |
Landthaler, M | 1 |
Baran, R | 1 |
Ceschin-Roques, CG | 1 |
Hänel, H | 1 |
Pruja-Bougaret, SM | 1 |
Luc, J | 1 |
Vandermander, J | 1 |
Michel, G | 1 |
Yu, B | 1 |
Zhou, G | 1 |
Wang, B | 2 |
Ben, Y | 1 |
Yan, H | 1 |
Shao, Y | 1 |
Dompmartin, D | 1 |
Dompmartin, A | 1 |
Deluol, AM | 1 |
Coulaud, JP | 1 |
Rollman, O | 1 |
Johansson, S | 1 |
Reviews
3 reviews available for ciclopirox and Hand Dermatosis
Article | Year |
---|---|
Economic analysis of oral and topical therapies for onychomycosis of the toenails and fingernails.
Topics: Adult; Antifungal Agents; Ciclopirox; Cost-Benefit Analysis; Drug Costs; Economics, Pharmaceutical; | 2003 |
Topical and surgical treatment of onychomycosis.
Topics: Administration, Topical; Antifungal Agents; Ciclopirox; Combined Modality Therapy; Debridement; Foot | 1994 |
Dermatopharmacology of ciclopirox nail lacquer topical solution 8% in the treatment of onychomycosis.
Topics: Administration, Topical; Animals; Antifungal Agents; Cattle; Ciclopirox; Clinical Trials as Topic; D | 2000 |
Other Studies
13 other studies available for ciclopirox and Hand Dermatosis
Article | Year |
---|---|
Onychomycosis: current and future therapies.
Topics: Antifungal Agents; Boron Compounds; Bridged Bicyclo Compounds, Heterocyclic; Ciclopirox; Debridement | 2014 |
Sporicidal effect of amorolfine and other antimycotics used in the therapy of fungal nail infections.
Topics: Antifungal Agents; Candida albicans; Ciclopirox; Epidermophyton; Fluconazole; Hand Dermatoses; Human | 2015 |
Treatment costs of three nail lacquers used in onychomycosis.
Topics: Adult; Antifungal Agents; Ciclopirox; Drug Costs; Europe; Female; Foot Dermatoses; Hand Dermatoses; | 2005 |
Congenital candidal onychomycoses: effective cure with ciclopirox olamine 8% nail lacquer.
Topics: Administration, Topical; Antifungal Agents; Candidiasis; Ciclopirox; Hand Dermatoses; Humans; Infant | 2006 |
Identification and in vitro antifungal susceptibility testing of 200 clinical isolates of Candida spp. responsible for fingernail infections.
Topics: Antifungal Agents; Brazil; Candida; Candidiasis; Ciclopirox; Fluconazole; Hand Dermatoses; Humans; I | 2007 |
In Vitro penetration of a novel oxaborole antifungal (AN2690) into the human nail plate.
Topics: Antifungal Agents; Boron Compounds; Bridged Bicyclo Compounds, Heterocyclic; Chemistry, Pharmaceutic | 2007 |
[Cutaneous and nail infections caused by Hendersonula toruloidea].
Topics: Adult; Antifungal Agents; Ciclopirox; Dermatomycoses; Diagnosis, Differential; Female; Hand Dermatos | 1993 |
[Treatment of therapy refractory verrucae vulgares with a ciclopirox-containing lacquer].
Topics: Administration, Topical; Adolescent; Adult; Antifungal Agents; Child; Ciclopirox; Drug Administratio | 2001 |
[New treatments of onychomycoses].
Topics: Administration, Topical; Antifungal Agents; Candidiasis; Ciclopirox; Fluconazole; Foot Dermatoses; H | 1992 |
Ciclopirox nail lacquer 8%: in vivo penetration into and through nails and in vitro effect on pig skin.
Topics: Administration, Topical; Animals; Antifungal Agents; Biological Transport; Candida; Ciclopirox; Cosm | 1991 |
A clinical and laboratory study of ciclopirox olamine (8% Batrafen) in the treatment of onychomycosis.
Topics: Adult; Aged; Antifungal Agents; Candida albicans; Ciclopirox; Female; Foot Dermatoses; Hand Dermatos | 1991 |
Onychomycosis and AIDS: treatment with topical ciclopirox olamine.
Topics: Acquired Immunodeficiency Syndrome; Administration, Topical; Antifungal Agents; Ciclopirox; Hand Der | 1990 |
Hendersonula toruloidea infection: successful response of onychomycosis to nail avulsion and topical ciclopiroxolamine.
Topics: Administration, Cutaneous; Adult; Antifungal Agents; Ciclopirox; Hand Dermatoses; Humans; Male; Mito | 1987 |